Skip to main content

CLSD

Stock
Health Care
Biotechnology

Performance overview

CLSD Price
Price Chart

Forward-looking statistics

Beta
1.09
Risk
72.19%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

clearside biomedical, inc. is a pharmaceuticals company located in 1220 old alpharetta rd., suite 300, alpharetta, ga, united states.

Company info

SectorHealth Care
IndustryBiotechnology
Employees34
Market cap$91.2M

Fundamentals

Enterprise value$102.6M
Revenue$3.8M
Revenue per employee—
Profit margin91.05%
Debt to equity-1.18

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.41
Dividend per share—
Revenue per share$0.05
Avg trading volume (30 day)$270K
Avg trading volume (10 day)$167K
Put-call ratio—

Macro factor sensitivity

Growth-5.5
Credit+10.3
Liquidity+2.1
Inflation-8.7
Commodities-3.8
Interest Rates-3.7

Valuation

Dividend yield0.00%
PEG Ratio-1.62
Price to sales16.77
P/E Ratio-1.62
Enterprise Value to Revenue27.26
Price to book-1.36

Upcoming events

Next earnings dayMay 15, 2025
Next dividend day—
Ex. dividend day—

News

Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know

Clearside Biomedical (CLSD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research (May 29, 2025)
Why Is Clearside Biomedical Stock Gaining Today?

Oppenheimer initiated coverage on Clearside Biomedical Inc CLSD, a biopharmaceutical company focused on delivering therapies to the back of the eye through the suprachoroidal (SCS) space.

Benzinga (June 25, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free